124 related articles for article (PubMed ID: 17631905)
1. ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers.
Kawano O; Sasaki H; Endo K; Suzuki E; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
J Surg Res; 2008 May; 146(1):43-8. PubMed ID: 17631905
[TBL] [Abstract][Full Text] [Related]
2. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
Sonobe M; Nakagawa M; Takenaka K; Katakura H; Adachi M; Yanagihara K; Otake Y; Wada H; Tanaka F
J Surg Oncol; 2007 Jan; 95(1):63-9. PubMed ID: 17192868
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
[TBL] [Abstract][Full Text] [Related]
5. CCND1 messenger RNA expression is correlated with EGFR mutation status in lung cancer.
Sasaki H; Okuda K; Endo K; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
Clin Lung Cancer; 2007 Sep; 8(8):493-6. PubMed ID: 17922974
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
Brabender J; Danenberg KD; Metzger R; Schneider PM; Park J; Salonga D; Hölscher AH; Danenberg PV
Clin Cancer Res; 2001 Jul; 7(7):1850-5. PubMed ID: 11448895
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
8. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
Dacic S; Flanagan M; Cieply K; Ramalingam S; Luketich J; Belani C; Yousem SA
Am J Clin Pathol; 2006 Jun; 125(6):860-5. PubMed ID: 16690485
[TBL] [Abstract][Full Text] [Related]
9. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.
Haneda H; Sasaki H; Lindeman N; Kawano O; Endo K; Suzuki E; Shimizu S; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Feb; 36(2):69-75. PubMed ID: 16449241
[TBL] [Abstract][Full Text] [Related]
10. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor mutations in small cell lung cancer.
Tatematsu A; Shimizu J; Murakami Y; Horio Y; Nakamura S; Hida T; Mitsudomi T; Yatabe Y
Clin Cancer Res; 2008 Oct; 14(19):6092-6. PubMed ID: 18829487
[TBL] [Abstract][Full Text] [Related]
12. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
13. Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer.
Cortas T; Eisenberg R; Fu P; Kern J; Patrick L; Dowlati A
Lung Cancer; 2007 Mar; 55(3):349-55. PubMed ID: 17161498
[TBL] [Abstract][Full Text] [Related]
14. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase 1 mRNA expression in lung cancer.
Sasaki H; Moriyama S; Nakashima Y; Kobayashi Y; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Lung Cancer; 2004 Nov; 46(2):171-8. PubMed ID: 15474665
[TBL] [Abstract][Full Text] [Related]
16. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.
López-Malpartida AV; Ludeña MD; Varela G; García Pichel J
Lung Cancer; 2009 Jul; 65(1):25-33. PubMed ID: 19046792
[TBL] [Abstract][Full Text] [Related]
17. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
18. ErbB4 expression and mutation in Japanese patients with lung cancer.
Sasaki H; Okuda K; Kawano O; Endo K; Yukiue H; Yokoyama T; Yano M; Fujii Y
Clin Lung Cancer; 2007 Jul; 8(7):429-33. PubMed ID: 17681096
[TBL] [Abstract][Full Text] [Related]
19. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
